Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

Liquidating Share Class Distribution Announcement

22 Feb 2023 07:00

RNS Number : 6346Q
Marble Point Loan Financing Limited
22 February 2023
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSONS, WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW.

 

22 February 2023

 

Marble Point Loan Financing Limited

Liquidating Share Class Distribution

The Directors of Marble Point Loan Financing Limited (the "Company") have announced a distribution to holders of the Company's Liquidating Shares created via redesignation of Ordinary Shares effective on the Conversion Date 1 January 2023 (such Liquidating Shares hereinafter referred to as the "2023 Liquidating Shares") of $0.0179 per 2023 Liquidating Share. The distribution will be payable to holders of the Company's 2023 Liquidating Shares as detailed below:

 

Distribution[1]:

$0.0179 per 2023 Liquidating Share

Record Date:

20 February 2023

Payment Date:

28 February 2023

Liquidating Shares Outstanding[2]

49,741,723

 

Past performance is not indicative, or a guarantee, of future performance.

This release contains inside information.

ENQUIRIES

Marble Point Loan Financing Limited

Investor Relations

Tel.: +44 (0) 20 7259 1500

Email:  ir@mplflimited.com

Corporate Broker

Stifel Nicolaus Europe Limited

T: +44 (0) 20 7710 7600

 

 

 

 

 

 

 

 

ABOUT MARBLE POINT LOAN FINANCING LIMITED

Marble Point Loan Financing Limited (the "Company") is a Guernsey closed-ended investment company with its ordinary shares admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange (tickers: MPLF LN / MPLS LN). The Company is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans via CLOs, loan accumulation facilities and other vehicles managed by Marble Point Credit Management LLC or its affiliates. For more information, please visit the Company's website: www.mplflimited.com.

LEI: 549300DWXSN5UC85CL26

 

IMPORTANT INFORMATION

This document is provided for informational purposes only and does not constitute an offer to sell any shares, notes or other securities (collectively, "Securities") issued by the Company or a solicitation of an offer to purchase any such Securities in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction. This document may not be relied upon, and should not be used, for the purpose of making any investment decision. The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940 and investors will not be entitled to the benefits of such Act.

Past performance is not a reliable indicator of current of future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

Past performance is not a reliable indicator of current or future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

This document is for information purposes only. No recipient may forward, reproduce, distribute, or make available in whole or in part, this document (directly or indirectly) to any other person. The distribution of this document in certain jurisdictions may be restricted by law and recipients of this document should inform themselves about and observe any such restrictions and other applicable legal requirements in their jurisdictions. This document, and the information contained therein, is not for viewing, release, distribution or publication in or into the United States, Australia, Canada, the Republic of South Africa or Japan or any other jurisdiction where applicable laws prohibit its release, distribution or publication, and will not be made available to any national, resident or citizen of the United States, Australia, Canada, the Republic of South Africa or Japan. The distribution of this document in other jurisdictions may be restricted by law and persons into whose possession this document comes must inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the federal securities law of the United States or the laws of other jurisdictions. 

The Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, and investors will not be entitled to the benefits of such Act.

There is no guarantee that any of the goals, targets or objectives described in this document will be achieved. The investment strategies of the Company described herein may not be suitable for all investors and are not intended to constitute a complete investment program. Neither Marble Point nor the Company makes any representation or warranty (express or implied) with respect to the information contained herein (including, without limitation, information obtained from third parties) and each of them expressly disclaims any and all liability based on or relating to the information contained in, or errors or omissions from, these materials; or based on or relating to the use of these materials; or any other written or oral communications transmitted to the recipient or any of its affiliates or representatives in the course of its evaluation of the information herein.

None of the Company, Marble Point or any of their respective parent or subsidiary undertakings, or the subsidiary undertaking of any such parent undertakings, or any of such person's respective partners, shareholders, directors, members, officers, affiliates, agents, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any information or opinions presented or contained in this document nor shall they accept any responsibility whatsoever for, or make any warranty, express or implied, as to the truth, fullness, accuracy or completeness of the information in this document (or whether any information has been omitted from the document) or any other information relating to the Company, Marble Point or their respective subsidiaries or associated companies, in any form whatsoever, howsoever transmitted or made available or for any loss howsoever arising from any use of this document or its contents or otherwise arising in connection therewith. This shall not affect any liability any such person may have which may not be excluded under applicable law or regulation.

A Note on Forward Looking Statements. This document includes forward-looking statements. Forward-looking statements include all matters that are not historical facts. Actual results may differ materially from any results projected in the forward-looking statements and are subject to risks and uncertainties. Such statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, and other factors that may cause actual results to differ materially from the anticipated results expressed or implied by such forward-looking statements. The Company and Marble Point caution readers not to place undue reliance on such statements. Neither the Company nor Marble Point undertakes, and each specifically disclaims, any obligation or responsibility, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. Actual results may differ materially from the Company's and/or Marble Point's expectations and estimates.

The information provided herein is estimated, unaudited, for background purposes only, representative as at the dates specified herein, subject to adjustment and not purported to be full or complete. Nothing herein shall be relied upon as a representation as to the current or future performance or portfolio holdings of the Company or any strategy or investment vehicle. Certain information presented herein has been obtained from third party sources and is believed to be reliable. However, neither the Company nor Marble Point represents that the information contained in this document (including third party information) has been independently verified or is accurate or complete, and it should not be relied upon as such. Index information, if any, has been provided for illustration purposes only. Any such information does not reflect the effect of transaction costs, management fees or other costs which would reduce returns. An investor cannot invest directly in an index.

Any of the views or opinions expressed herein are current views and opinions only and may be subject to change. Statements made herein are as of the date of this document and should not be relied upon as of any subsequent date. All information is current as of the date of this document and is subject to change without notice.

 


[1] The Company pays distributions in U.S. Dollars. Shareholders will, by default, receive their cash distributions in U.S. Dollars.

[2] On 1 January 2023, 49,741,723 of the Company's Ordinary Shares were redesignated to its Liquidating Share Class. As at the date of this announcement, 149,225,169 Ordinary Shares remain outstanding.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADAFAFSDEAA
Date   Source Headline
23rd May 20227:00 amRNSNet Asset Value & Publication of Monthly Report
23rd May 20227:00 amRNS1st Quarter Results
22nd Apr 20224:36 pmRNSDividend Declaration
21st Apr 20227:00 amRNSNet Asset Value & Publication of Monthly Report
8th Apr 20225:09 pmRNSAnnual Financial Report
31st Mar 20226:00 pmRNSDividend Declaration
24th Mar 20227:00 amRNSNet Asset Value & Publication of Monthly Report
21st Feb 20227:00 amRNSNet Asset Value & Publication of Monthly Report
31st Jan 20223:25 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSNet Asset Value & Publication of Monthly Report
20th Jan 20225:33 pmRNSDividend Declaration
4th Jan 20227:00 amRNSDirector/PDMR Shareholding
29th Dec 20217:00 amRNSDividend Declaration
23rd Dec 20217:00 amRNSNet Asset Value & Publication of Monthly Report
24th Nov 20217:00 amRNS3rd Quarter Results
23rd Nov 20217:00 amRNSNet Asset Value & Publication of Monthly Report
19th Nov 20213:23 pmRNSResult of AGM
9th Nov 20215:21 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSNotice of AGM
3rd Nov 20214:25 pmRNSTransaction in Own Shares
27th Oct 20217:00 amRNSTransaction in Own Shares
21st Oct 20215:21 pmRNSDividend Declaration
21st Oct 20217:00 amRNSNet Asset Value & Publication of Monthly Report
12th Oct 20216:00 pmRNSShort Form Amalgamation Announcement
22nd Sep 20217:00 amRNSNet Asset Value & Publication of Monthly Report
17th Sep 20217:00 amRNSInvestment in Marble Point CLO XXI
14th Sep 20217:00 amRNSDividend Declaration
13th Sep 20216:00 pmRNSSHORT FORM AMALGAMATION ANNOUNCEMENT
13th Sep 20216:00 pmRNSHalf-year Report
8th Sep 20216:00 pmRNSDirector/PDMR Shareholding
25th Aug 20217:00 amRNSNet Asset Value & Publication of Monthly Report
6th Aug 20217:00 amRNSPublication of Key Investor Document
5th Aug 20217:00 amRNSInvestment in Marble Point CLO XXII
21st Jul 20216:00 pmRNSSterling Dividend Amount
20th Jul 20217:00 amRNSNet Asset Value & Publication of Monthly report
1st Jul 20217:00 amRNSDividend Declaration
1st Jul 20217:00 amRNSB Share Voting Rights
28th Jun 20216:00 pmRNSDirector/PDMR Shareholding
28th Jun 20216:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSNet Asset Value & Publication of Monthly Report
14th Jun 20217:00 amRNSMP CLO VIII Reset Closing
1st Jun 20216:00 pmRNS1st Quarter Results
25th May 20217:00 amRNSInvestment in Marble Point CLO XX
24th May 20217:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Apr 20217:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Apr 20216:00 pmRNSSterling Dividend Amount
9th Apr 20216:00 pmRNSAnnual Financial Report
30th Mar 20217:00 amRNSDividend Declaration
24th Mar 20217:00 amRNSNet Asset Value & Publication of Monthly Report
26th Feb 20217:00 amRNSQ1 2021 Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.